Recently, it was shown that SCLC lacking ASCL1, NEUROD1, and POU2F3 (some ∼18%) is enriched for inflammation and immune response genes and shows improved immune checkpoint blockade response (Gay et al., 2021). This evidence concerns the gene POU2F3 and small cell lung carcinoma.